Zhang F, Vierock J, Yizhar O, et al. The microbial opsin family of optogenetic tools. Cell. 2011;147(7):1446-57. doi:10.1016/j.cell.2011.12.004
Pretorius J, Bray MAP, Carpenter AE, Ruddle RA. Visualization of parameter space for image analysis. IEEE Trans Vis Comput Graph. 2011;17(12):2402-11. doi:10.1109/TVCG.2011.253
Hoang LT, Lynn DJ, Henn M, et al. The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults. J Virol. 2010;84(24):12982-94. doi:10.1128/JVI.01224-10
Paulovich AG, Billheimer D, Ham AJL, et al. Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance. Mol Cell Proteomics. 2010;9(2):242-54. doi:10.1074/mcp.M900222-MCP200
Thomas RK, Baker AC, Debiasi RM, et al. High-throughput oncogene mutation profiling in human cancer. Nat Genet. 2007;39(3):347-51. doi:10.1038/ng1975
Raychaudhuri S, Sandor C, Stahl EA, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet. 2012;44(3):291-6. doi:10.1038/ng.1076
Kathiresan S, Srivastava D. Genetics of human cardiovascular disease. Cell. 2012;148(6):1242-57. doi:10.1016/j.cell.2012.03.001
Germain AR, Carmody LC, Morgan B, et al. Identification of a selective small molecule inhibitor of breast cancer stem cells. Bioorg Med Chem Lett. 2012;22(10):3571-4. doi:10.1016/j.bmcl.2012.01.035
Benassi B, Flavin R, Marchionni L, et al. MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer. Cancer Discov. 2012;2(3):236-47. doi:10.1158/2159-8290.CD-11-0219
Choudhury AD, Eeles R, Freedland SJ, et al. The role of genetic markers in the management of prostate cancer. Eur Urol. 2012;62(4):577-87. doi:10.1016/j.eururo.2012.05.054